$BIO Introduction
BIO Protocol (BIO Coin) is a platform for funding and commercializing decentralized science (DeSci), unlocking opportunities for biotechnology innovation and scientific funding.
BIO enables a global community of patients, scientists, and biotech investors to co-fund, build, and own tokenized biotech projects and intellectual property (IP).
Project Mission
BIO Protocol's mission is to enable groundbreaking science to be achieved faster by allowing individuals rather than institutions to fund and commercialize biotechnology.
Value Proposition
BIO's launchpad and liquidity protocol allow liquid markets and on-chain communities to form efficiently around the best early-stage science. BIO brings structure and incentives to distributed R&D efforts, creating valuable scientific intellectual property outside of the traditional pharmaceutical space.
Science funding issues:
1. Time-consuming grant process: Scientists spend up to 80% of their time applying for grants, which affects valuable research and slows progress in key areas.
2. Valley of Death: Many promising early discoveries never reach commercialization due to high risk, resource gaps, and lack of support, hindering the progress of biotechnology.
3. Concentration of Funding: Because funding is concentrated in a few geographical centers, most of the world’s scientific talent remains untapped.
4. Complex intellectual property and licensing barriers: Fragmented intellectual property ownership and challenging licensing agreements hinder collaboration and prevent biotechnology innovations from quickly entering the market.
5. Low patient engagement: Most research is conducted away from the patient community, leading to misaligned incentives between scientists and patients.
BIO solves the problem by:
Decentralized funding: Allowing anyone to invest in promising biotech projects.
1. Capital efficiency: Pooling resources (patient data, capital, labor) to reduce the cost of biotechnology innovation.
2. Diversified investment portfolio: BIO bundles together an investment portfolio of biotechnology projects to reduce the risk of biotechnology investments through diversification.
3. Global talent and capital pool: enabling scientists, researchers and investors around the world to contribute labor or capital to specific therapeutic areas or drugs.
4. Shared IP ownership: Represents the biotech DAO and the joint ownership of scientific IP as tokens.
5. Liquid Market: Providing early liquidity to traditionally illiquid biotech assets.
6. Open access: removing gatekeepers from science funding and decision-making.
Token Function
BIO is the governance token of the BIO protocol and is used for the following functions:
1. Governance and decentralization: BIO tokens grant holders governance rights over the BIO protocol and meta-governance rights over the BioDAO in the network.
2. Whitelist Access: BIO tokens provide holders with whitelist access to BioDAO funding rounds and tokenized IP on the network.
3. Curation: BioDAOs selected by BIO holders are launched through the BIO Launchpad and receive support from the network in terms of funding and liquidity.
4. Connecting to BioDAO: BIO represents a basket of DeSci tokens, as the BioDAO in the network contributes a certain percentage of its initial token supply to the protocol in exchange for funding, liquidity, and acceleration services.
5. Protocol Liquidity: BIOProtocol provides liquidity through BioDAO tokens and IP tokens in its treasury, earning transaction fees from the liquidity owned by its protocol.
Technical Details
BIO brings cutting-edge DeFi mechanisms to DeSci, borrowing management and liquidity mechanisms from platforms/protocols such as Pump.fun and Virtuals.
At the heart of BIO is its Launchpad and Liquidity Protocol, which allows the BIO community to decide which DAOs receive support in the form of funding, liquidity, and incentives during launch and throughout the DAO lifecycle.
BIO Launchpad is divided into three distinct phases:
1. Governance: BIO holders vote to decide whether to allow projects to be launched through the BIO protocol. Curators donate their BIO commitments to BioDAOs they think are promising.
2. Acceleration (Funding): This phase allows the project to raise the first funds from users. This can be achieved through auctions or bonding curve mechanisms.
3. Separation (AMM Liquidity): The final stage releases the project to the open market supported by deep on-chain liquidity pools. BIO Protocol acts as a liquidity engine through its BIO/BioDAO liquidity pool pairing.
Token Allocation
An Launchpool: 3.00% of total supply
Team: 21.20% of total supply
Advisors: 4.70% of total supply
Private placement investors: 13.60% of total supply (Molecule AG investors (pro rata) 7.60% of total supply, Pre-Seed and Seed investors 6.00% of total supply)
Molecule AG: 5.00% of total supply
Community Auction/Public Investors: 20.00% of the total supply
Community Airdrop: 6.00% of the total supply (Community Airdrop-1 accounts for 1.00% of the total supply, Community Airdrop-2 accounts for 3.00% of the total supply, Community Airdrop-3 accounts for 2.00% of the total supply)
Molecule Community Fund: 5.00% of total supply
Ecosystem incentives (bio/acc rewards): 4.00% of total supply
Ecosystem Incentives (Treasury): 15.00% of total supply
Liquidity and Marketing: 2.50% of total supply
